![Adrian Hepner](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Adrian Hepner
Direttore/Membro del Consiglio presso
ADVICENNE
Profilo
Adrian J.
Hepner is currently an Independent Director at Advicenne SA since 2026.
Former positions include Senior Medical Director at UCB Biosciences, Inc. from 2012 to 2013; Vice President-Clinical Research at Avanir Pharmaceuticals, Inc. from 2006 to 2012; VP-Clinical Research & Medical Affairs at BioDelivery Sciences International, Inc. from 2013 to 2014; Chief Medical Officer & Executive Vice President at Eagle Pharmaceuticals, Inc. from 2016 to 2020; Chief Medical Officer at Pharnext SA from 2020 to 2022; and President & Chief Medical Officer at Coya Therapeutics, Inc. from 2021 to 2023.
Education includes graduate and doctorate degrees from Universidad de Buenos Aires, conferred in 1986 and 1983 respectively.
Posizioni attive di Adrian Hepner
| Società | Posizione | Inizio |
|---|---|---|
| ADVICENNE | Direttore/Membro del Consiglio | 21/05/2026 |
Precedenti posizioni note di Adrian Hepner
| Società | Posizione | Fine |
|---|---|---|
| COYA THERAPEUTICS, INC. | Presidente | 17/07/2023 |
| PHARNEXT SCA | Direttore Tecnico/Scientifico/R&S | 01/01/2022 |
| EAGLE PHARMACEUTICALS, INC. | Direttore Tecnico/Scientifico/R&S | 31/07/2020 |
| BIODELIVERY SCIENCES INTERNATIONAL, INC. | Direttore Tecnico/Scientifico/R&S | 01/12/2014 |
UCB BioSciences, Inc. | Corporate Officer/Principal | 01/01/2013 |
Formazione di Adrian Hepner
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
68
Relazioni di 1° grado
8
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 8 |
|---|---|
Avanir Pharmaceuticals, Inc.
 Avanir Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic products for the treatment of nervous system disorder | Health Technology |
BioDelivery Sciences International, Inc.
 BioDelivery Sciences International, Inc. Pharmaceuticals: MajorHealth Technology Operates as a commercial stage pharmaceutical company to patients living with chronic pain | Health Technology |
Eagle Pharmaceuticals, Inc.
 Eagle Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercialize injectable products primarily in the metabolic critical care and oncology | Health Technology |
Universidad de Buenos Aires
 Universidad de Buenos Aires Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pharnext SA
 Pharnext SA Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops therapies for patients to treat neurodegenerative diseases | Health Technology |
UCB BioSciences, Inc. | Electronic Technology |
Advicenne SA
 Advicenne SA Pharmaceuticals: GenericHealth Technology Develops and markets pediatric drugs | Health Technology |
Coya Therapeutics, Inc.
 Coya Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that focuses on research and development of therapies to enhance the function of regulatory T cells | Health Technology |
